The Chinese Society for Immunology (CSI), a voluntary, national, academic, non-profit and non-governmental organization, formed from the national scientific and technical immunologists, is registered and established in accordance with the laws of China. CSI has grown out of the Chinese Committee for Immunology, which was founded in 1984, and became a member of the International Union of Immunological Societies (IUIS) in the same year. The formal proceedings to establish CSI began in 1988 after it was approved and affiliated with the China Association for Science and Technology. In 1992, CSI became a member of The Federation of Immunological Societies of Asia-Oceania (FIMSA). Currently, the society possesses over 10000 members and 3500 members belong to the IUIS.

President
Zhigang Tian, MD, PhD

Secretary-General
Xuetao Cao, MD, PhD

 
Official Journal of CSI

International Meetings of Interest


The Keystone Symposia 2019 Innate Immunity Conference
(March 10 - 14, 2019, Taipei City, China)

NATURE CONFERENCE Grand Challenges in Immunology: Immunotherapy for Cancer and Beyond
(June 11 - 13, 2019, Qingdao, China)

17th International Congress of Immunology
(October 18 - 23, 2019, Beijing, China)

News


Prof. Xue-Min Zhang and Tao Li revealed that G3BP1 is critical for the DNA-binding and activation of cGAS

Chinese scientists find how PD-1, a key drug target for cancer immunotherapy, is degraded in T cells

Prof. Weijun Pan’s group revealed usher cells guide homing of HSPCs to a vascular niche

Prof. Baidong Hou‘s group revealed an unexpected pathway by which naïve CD4+ T cells are activated

Prof. Di Wang’s group revealed a new mechanism of intermodulation between immune system and metabolism

Prof. Wanli Liu and Zhanguo Li published a Science paper reporting a novel mechanism on the regulation and activation of B lymphocytes in autoimmune diseases

Prof. Xuetao Cao’s Group sheds new insight into the origin of connective tissue-resident mast cells

Prof. Yonghui Zhang’s Group Revealed New Immune Regulation Mechanism of Mevalonate Pathway

13th CSI Annual Meeting

New FIMSA Council Elected

Chinese Scholars Unveil New Mechanisms Responsible for the Synergistic Effect of ICIs and Therapeutic Antibodies

Dr. Feng Shao’s laboratory discovered a novel anti-bacterial pattern recognition receptor

Prof. Erwei Song and Shicheng Su’s group revealed a new mechanism of tumor immune evasion regulated by an lncRNA

Summer School 2018 of CSI